| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Feb 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO & Secretary | Sell | 42.5 | -329 | -7.37% | ✗ | $51.1K |
| Feb 1, 2024 | Feb 5, 2024 | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO & Secretary | Sell | 40.0 | -1,591 | -30.74% | ✗ | $272.1K |
| Apr 6, 2023 | Apr 10, 2023 | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO & Secretary | Sell | 7.5 | -3,500 | -100.00% | ✓ | $735K |
| Feb 1, 2023 | Feb 3, 2023 | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO & Secretary | Sell | 40.0 | -1,675 | -32.37% | ✗ | $378.6K |